SS Innovations Wins Top Surgical Robotics Industry Award

In a major industry recognition, SS Innovations International Inc. (NASDAQ: SSII) has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards. The company, a developer of innovative surgical robotic technologies, was selected from a competitive field of ten finalists that included industry giants such as Intuitive, Johnson & Johnson MedTech, and Medtronic. The award, based on criteria including commercial performance, technological innovation, societal impact, and ethical standards, highlights SS Innovations' growing influence in the surgical robotics space. Chairman and CEO Dr. Sudhir Srivastava emphasized that the recognition reflects the company's mission to expand access to robotic surgery while improving affordability for hospitals and healthcare systems.

This accolade comes at a time of significant operational growth for SS Innovations' flagship product, the SSi Mantra surgical robotic platform. As of June 22, 2026, surgeons have completed a cumulative 11,719 multi-specialty procedures using the system, including 612 cardiac surgeries, 175 telesurgeries, and 212 pediatric operations. The platform's versatility is demonstrated by its use across more than 170 different types of surgical procedures. Training has also expanded, with approximately 2,100 physicians trained on the system, a critical factor for adoption as hospitals consider robotic surgery investments. The company's international footprint continues to broaden, with regulatory approvals now granted in 14 countries, including Colombia, India, and the United Arab Emirates, supporting its global growth strategy. The SSi Mantra is a modular, multi-arm system with 3D 4K visualization, an ergonomic surgeon console, and over 40 robotic instruments, including 5-millimeter tools for pediatric and ENT procedures. Additionally, the company has developed the SSi MantrAsana, a portable tele-surgeon console that has enabled over 20 cardiac telesurgeries, showcasing its potential in remote surgical applications.

For investors, this independent industry endorsement provides validation as SS Innovations continues to expand in the rapidly growing global surgical robotics market. The award not only recognizes the company's technological advancements but also its commitment to ethical practices and societal impact. As the surgical robotics industry becomes increasingly competitive, with healthcare providers adopting robotic-assisted procedures across multiple specialties, SS Innovations' recognition positions it as a key player to watch. The company's focus on affordability and training could drive further adoption, making robotic surgery more accessible worldwide. With over 11,700 procedures completed and regulatory approvals in 14 countries, SS Innovations is poised for continued growth, potentially reshaping the landscape of minimally invasive surgery.